American Capital Management Inc Repligen Corp Transaction History
American Capital Management Inc
- $2.67 Billion
- Q4 2024
A detailed history of American Capital Management Inc transactions in Repligen Corp stock. As of the latest transaction made, American Capital Management Inc holds 383,529 shares of RGEN stock, worth $60.5 Million. This represents 2.06% of its overall portfolio holdings.
Number of Shares
383,529
Previous 379,034
1.19%
Holding current value
$60.5 Million
Previous $56.4 Million
2.13%
% of portfolio
2.06%
Previous 1.85%
Shares
26 transactions
Others Institutions Holding RGEN
# of Institutions
482Shares Held
56.3MCall Options Held
251KPut Options Held
458K-
Black Rock Inc. New York, NY7.57MShares$1.19 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$1.13 Billion0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$804 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$267 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$243 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.75B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....